Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to ...

The FDA’s hold, which Novavax was informed of Friday, responds to a report last month of a serious adverse event of motor neuropathy in a participant in the company’s Phase 2 trial of the ...

"Fundamentally this doesn't seem to have a direct impact on Novavax's partnership with Sanofi," TD Cowen analyst Brendan Smith said. Investors will closely monitor what additional data the FDA ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...

However, recent news represents a setback for Novavax's combined vaccine candidate. The U.S. Food and Drug Administration (FDA) ordered a temporary halt to the program and to the company's stand ...

The company said it was working with the FDA to get the information necessary to resolve the issue and allow the company to move forward with testing. Novavax (NVAX) shares plummeted nearly 20% ...